Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer
- PMID: 12892799
- DOI: 10.1016/S1072-7515(03)00539-8
Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer
Abstract
Background: Peritoneal dissemination is the most frequent mode of recurrence in patients with gastric cancer. We tried to identify factors that predict peritoneal recurrence with high sensitivity.
Study design: Clinical and pathologic data from 587 consecutive patients with gastric cancer were reviewed retrospectively. The stepwise Cox proportional hazards regression model was used to assess the prognostic significance of the magnitude of serosal changes. Multiple stepwise logistic regression analysis was used to determine factors associated with peritoneal recurrence in 375 patients who underwent curative resection.
Results: The 5-year survival rate of patients with S2 disease (greatest dimension of macroscopic serosal changes >/= 2.5 cm) was 18%, which was worse than S0 (no serosal changes) and S1 disease (macroscopic serosal changes < 2.5 cm)(p < 0.001). Patients with S0 tumors who underwent curative resection had the best 5-year survival rate. Multivariate analyses indicated that the magnitude of serosal changes was an independent prognostic factor for survival both overall and after curative resection. Logistic regression analysis showed that peritoneal recurrence was more than four times as likely with S2 than with S0 or S1 tumors. The sensitivity for predicting peritoneal recurrence was 79%; the sensitivity of cytologic examination was 38%.
Conclusions: Magnitude of serosal changes is easy to measure intraoperatively and predicts peritoneal recurrence of gastric cancer with greater sensitivity than conventional peritoneal lavage cytology.
Similar articles
-
Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.Ann Surg Oncol. 2011 Apr;18(4):1068-80. doi: 10.1245/s10434-010-1449-6. Epub 2010 Dec 14. Ann Surg Oncol. 2011. PMID: 21293933
-
Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.Hepatogastroenterology. 2007 Oct-Nov;54(79):2028-31. Hepatogastroenterology. 2007. PMID: 18251153
-
Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure.J Exp Clin Cancer Res. 2002 Dec;21(4):547-53. J Exp Clin Cancer Res. 2002. PMID: 12636101
-
Multivariate prognostic study on large gastric cancer.J Surg Oncol. 2007 Jul 1;96(1):14-8. doi: 10.1002/jso.20631. J Surg Oncol. 2007. PMID: 17582596 Review.
-
Peritoneal washing cytology in gastric cancer. How, when and who will get a benefit? A review.Minerva Gastroenterol Dietol. 2011 Mar;57(1):43-51. Minerva Gastroenterol Dietol. 2011. PMID: 21372769 Review.
Cited by
-
The role of endoscopic ultrasound on the preoperative T staging of gastric cancer: A retrospective study.Medicine (Baltimore). 2016 Sep;95(36):e4580. doi: 10.1097/MD.0000000000004580. Medicine (Baltimore). 2016. PMID: 27603347 Free PMC article.
-
Staging of gastric cancer with the Clinical Stage Prediction score.World J Surg Oncol. 2019 Mar 8;17(1):47. doi: 10.1186/s12957-019-1589-5. World J Surg Oncol. 2019. PMID: 30849974 Free PMC article.
-
The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer.Ann R Coll Surg Engl. 2019 Apr;101(4):249-255. doi: 10.1308/rcsann.2018.0217. Epub 2019 Jan 3. Ann R Coll Surg Engl. 2019. PMID: 30602290 Free PMC article.
-
Significance of lavage cytology in advanced gastric cancer patients.World J Surg. 2010 Mar;34(3):563-8. doi: 10.1007/s00268-009-0355-1. World J Surg. 2010. PMID: 20054543
-
Clinical implication of serosal change in pathologic subserosa-limited gastric cancer.World J Surg. 2012 Feb;36(2):355-61. doi: 10.1007/s00268-011-1334-x. World J Surg. 2012. PMID: 22146944
MeSH terms
LinkOut - more resources
Full Text Sources
Medical